was read the article
array:23 [ "pii" => "S0301054612001115" "issn" => "03010546" "doi" => "10.1016/j.aller.2012.02.004" "estado" => "S300" "fechaPublicacion" => "2013-07-01" "aid" => "386" "copyright" => "SEICAP" "copyrightAnyo" => "2011" "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "cor" "cita" => "Allergol Immunopathol (Madr). 2013;41:273-5" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 1309 "formatos" => array:3 [ "EPUB" => 7 "HTML" => 803 "PDF" => 499 ] ] "itemSiguiente" => array:18 [ "pii" => "S0301054612001747" "issn" => "03010546" "doi" => "10.1016/j.aller.2012.04.008" "estado" => "S300" "fechaPublicacion" => "2013-07-01" "aid" => "405" "copyright" => "SEICAP" "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "cor" "cita" => "Allergol Immunopathol (Madr). 2013;41:275-6" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 928 "formatos" => array:3 [ "EPUB" => 8 "HTML" => 569 "PDF" => 351 ] ] "en" => array:9 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Research letter</span>" "titulo" => "The use of alternative medicine in children with atopic dermatitis" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "275" "paginaFinal" => "276" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "O.U. Soyer, I. Aksoy, Y. Dallar" "autores" => array:3 [ 0 => array:2 [ "nombre" => "O.U." "apellidos" => "Soyer" ] 1 => array:2 [ "nombre" => "I." "apellidos" => "Aksoy" ] 2 => array:2 [ "nombre" => "Y." "apellidos" => "Dallar" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0301054612001747?idApp=UINPBA00004N" "url" => "/03010546/0000004100000004/v1_201307160011/S0301054612001747/v1_201307160011/en/main.assets" ] "itemAnterior" => array:18 [ "pii" => "S0301054612003011" "issn" => "03010546" "doi" => "10.1016/j.aller.2012.07.018" "estado" => "S300" "fechaPublicacion" => "2013-07-01" "aid" => "470" "copyright" => "SEICAP" "documento" => "article" "crossmark" => 0 "subdocumento" => "rev" "cita" => "Allergol Immunopathol (Madr). 2013;41:265-72" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 3804 "formatos" => array:3 [ "EPUB" => 9 "HTML" => 3102 "PDF" => 693 ] ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Review</span>" "titulo" => "Allergen-specific immunotherapy: Update on immunological mechanisms" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "265" "paginaFinal" => "272" ] ] "contieneResumen" => array:1 [ "en" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0020" "etiqueta" => "Figure 4" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr4.jpeg" "Alto" => 2386 "Ancho" => 3175 "Tamanyo" => 302590 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">Allergen-specific Treg cells and their production of IL-10 and TGF-β: suppression of specific IgE production. Suppression of eosinophil, mast cells and basophil migration to tissues. Suppression of mucus production.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "M. Álvaro, J. Sancha, H. Larramona, J.M. Lucas, M. Mesa, A.I. Tabar, A. Martinez-Cañavate" "autores" => array:9 [ 0 => array:2 [ "nombre" => "M." "apellidos" => "Álvaro" ] 1 => array:2 [ "nombre" => "J." "apellidos" => "Sancha" ] 2 => array:2 [ "nombre" => "H." "apellidos" => "Larramona" ] 3 => array:2 [ "nombre" => "J.M." "apellidos" => "Lucas" ] 4 => array:2 [ "nombre" => "M." "apellidos" => "Mesa" ] 5 => array:2 [ "nombre" => "A.I." "apellidos" => "Tabar" ] 6 => array:2 [ "nombre" => "A." "apellidos" => "Martinez-Cañavate" ] 7 => array:1 [ "colaborador" => "Immunotherapy Working Group" ] 8 => array:1 [ "colaborador" => "Sociedad Española de Inmunología Clínica y Alergia Pediátrica (SEICAP)" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0301054612003011?idApp=UINPBA00004N" "url" => "/03010546/0000004100000004/v1_201307160011/S0301054612003011/v1_201307160011/en/main.assets" ] "en" => array:14 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Research letter</span>" "titulo" => "Allergy shots: Do patients feel pain or fear?" "tieneTextoCompleto" => true "saludo" => "<span class="elsevierStyleItalic">To the Editor</span>," "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "273" "paginaFinal" => "275" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "M.B. Ferreira, L.P. Viegas, A.S. Santos, M.P. Barbosa" "autores" => array:4 [ 0 => array:4 [ "nombre" => "M.B." "apellidos" => "Ferreira" "email" => array:1 [ 0 => "mbrancoferreira@gmail.com" ] "referencia" => array:3 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] 2 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">¿</span>" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "L.P." "apellidos" => "Viegas" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 2 => array:3 [ "nombre" => "A.S." "apellidos" => "Santos" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 3 => array:3 [ "nombre" => "M.P." "apellidos" => "Barbosa" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Immunoallergology Department, Hospital de Santa Maria, Centro Hospitalar Lisboa Norte, Portugal" "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Faculty of Medicine, University of Lisbon, Portugal" "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1336 "Ancho" => 1523 "Tamanyo" => 60152 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Boxplots of visual analogue scales (VAS) scores for pain and fear.</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Allergic respiratory diseases are usually treated with anti-inflammatory and/or anti-symptomatic drugs. However, not all patients are satisfied with pharmacotherapy even when drugs are provided free of charge.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> Subcutaneous immunotherapy (SCIT) has disease-modifying effects,<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a> and constitutes a cost-effective treatment of allergic asthma and/or rhinitis.<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> It has some disadvantages, such as the need for injections, monthly visits to allergy centres, and the possibility of local and/or systemic reactions, some of which may be severe. Although there are several studies evaluating children's pain associated with immunisation procedures, as far as we know there are no children or adult studies evaluating pain or fear associated with subcutaneous immunotherapy injections. In the present study we tried to assess if adult patients undergoing injective immunotherapy felt that allergy injections were painful or dangerous, using visual analogue scales (VAS), which are simple validated tools widely used to measure subjective aspects,<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a> such as the level of pain or fear associated with some procedures.</p><p id="par0010" class="elsevierStylePara elsevierViewall">We applied an anonymous questionnaire to all adult patients with respiratory allergy (asthma and/or rhinitis) that received a maintenance allergy shot with polymerised aeroallergen extracts in our department during the month of May 2010. Apart from the oral information that had been previously given by their attendant allergologists, all patients received, at the time of their first injections, written information concerning possible local and systemic reactions, being expressly advised that they should receive their allergy shots in a hospital setting because of the risk of important immediate side-effects that could be life-threatening.</p><p id="par0015" class="elsevierStylePara elsevierViewall">We excluded patients in the build-up phase of SCIT because we are now currently using, for patients’ convenience, a rush build-up scheme with two injections of polymerised extracts, performed on the same day with a 30–60<span class="elsevierStyleHsp" style=""></span>min interval, allowing to reach the maintenance dose on that same day. As it did not seem correct to compare days with two injections with days with only one injection, we chose to assess only patients receiving one maintenance injection (always 0.5<span class="elsevierStyleHsp" style=""></span>ml also to avoid bias of different volumes injected). Additionally, these patients already had some personal experience with the procedure, which was felt as an advantage to obtain a sound judgement. However, it can be reasonably argued that this inclusion criterion could have created a selection bias favouring the inclusion of patients who for any reason are compliant with SCIT or selecting those patients who have overcome their fear or pain associated with SCIT.</p><p id="par0020" class="elsevierStylePara elsevierViewall">The questionnaire was handed to the patient by the nurse, immediately after the injection, and was collected 30<span class="elsevierStyleHsp" style=""></span>min later, when the patient was re-evaluated before hospital discharge. The questionnaire comprised demographic (age, sex) and clinical data (year of SCIT initiation, presence of asthma and/or rhinitis) and two 100<span class="elsevierStyleHsp" style=""></span>mm VAS regarding intensity of pain, varying from 0 (no pain) to 100 (worst pain possible) and regarding apprehension/fear towards the allergy shots, varying from 0 (no apprehension/fear) to 100 (highest degree of apprehension/fear). The score was determined by the distance in millimetres from the starting point on the left end of the line up to the point marked by the patient.</p><p id="par0025" class="elsevierStylePara elsevierViewall">During this one-month study, 292 patients received an allergy shot in our department. We excluded 82 patients: 14 patients refused to participate; 46 patients were in the build-up phase; and 22 patients incorrectly fulfilled one or both VAS. Therefore we were able to analyse a total of 210 questionnaires (56% females). Patients’ mean age was 32.4<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>11.7 years (median 30 years; minimum 19; maximum 65 years). Most patients were in the first or second year of SCIT (mean SCIT duration 1.2<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>1.3 years; minimum 4 months, maximum 5 years). Both VAS data are presented in <a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>. Mean value for pain was 9.5<span class="elsevierStyleHsp" style=""></span>mm (minimum 0; median 0; 3rd quartile 19; maximum 40<span class="elsevierStyleHsp" style=""></span>mm). Fifty-three percent of our patients had a VAS pain score of zero. Mean value for VAS fear was 1.7<span class="elsevierStyleHsp" style=""></span>mm (minimum 0; median 0; 3rd quartile 0; maximum 30<span class="elsevierStyleHsp" style=""></span>mm). Eighty-nine percent of our patients had a VAS fear score of zero. Fear and pain VAS scores were weakly correlated (<span class="elsevierStyleItalic">r</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.22; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.03; Pearson). Females scored slightly higher on pain VAS (mean 11.4<span class="elsevierStyleHsp" style=""></span>mm in females versus 7.2<span class="elsevierStyleHsp" style=""></span>mm in males; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.032; chi-square) but both sexes scored equally on fear VAS. Age, type of allergens (mites or pollens) and type of allergic disease (asthma, rhinitis or both) had no statistically significant influence on pain or fear VAS scores. However, longer SCIT duration was associated with small, although statistically non-significant, increases in pain VAS score but not on fear VAS score (<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>). As reported in other studies we have observed a progressive reduction in the number of patients that continue regular SCIT-treatment throughout time, this reduction being particularly more marked after the second year of SCIT.</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0030" class="elsevierStylePara elsevierViewall">The results of this study clearly suggest that allergy shots are associated with low or absent levels of fear or pain, as self-reported by allergic patients, despite the fact that some physicians and non SCIT-treated patients may believe otherwise. Pain is a multidimensional experience involving a wide spectrum of affective and emotional factors. The concept of pain varies from person to person; nevertheless it can be defined as “an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage”.<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">5</span></a> Quantification of pain through VAS scores has allowed comparisons between different settings and between different individuals. In studies of postoperative pain, VAS scores of 0–4<span class="elsevierStyleHsp" style=""></span>mm are generally considered as representing no pain and between 5 and 44<span class="elsevierStyleHsp" style=""></span>mm to represent mild or acceptable pain.<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">6</span></a> Studies in diverse settings have proposed mild pain to be defined up to 36–50<span class="elsevierStyleHsp" style=""></span>mm in pain VAS,<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">7</span></a> while a very recent clinical trial in headache patients defined, by analysis of ROC curves, the following cut-off points for VAS scores: no pain 0–2<span class="elsevierStyleHsp" style=""></span>mm; mild pain 2–17<span class="elsevierStyleHsp" style=""></span>mm; moderate pain 17–47<span class="elsevierStyleHsp" style=""></span>mm; severe pain 47–77<span class="elsevierStyleHsp" style=""></span>mm; very severe pain 77–96<span class="elsevierStyleHsp" style=""></span>mm; and the most severe pain imaginable 96–100<span class="elsevierStyleHsp" style=""></span>mm.<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">8</span></a> In our study, all patients scored less than 40<span class="elsevierStyleHsp" style=""></span>mm, 53% scored zero and 75% scored 19 or less. This means that the perception of pain or perception of potential damage associated with allergy injections is not a very important issue in the majority of adult patients on maintenance SCIT with polymerised allergen vaccines, at least when injections are given by trained staff in a hospital setting. There is a slightly higher perception of pain by female patients, something that has already been reported in other pain studies.<a class="elsevierStyleCrossRefs" href="#bib0045"><span class="elsevierStyleSup">9,10</span></a> In our study, asthmatic patients had VAS pain scores very similar to rhinitis patients (9.3<span class="elsevierStyleHsp" style=""></span>mm versus 9.7<span class="elsevierStyleHsp" style=""></span>mm), without any significant differences. However it was not possible to evaluate the subgroup of asthmatic patients who had already been treated in an emergency department (and who could have previously had other painful experiences with injections) since no question regarding prior emergency room treatments was included in our questionnaire. The slight (but not significant) increase in pain scores that is seen with the increase in SCIT duration could perhaps be attributed to repeated local trauma but since we did not investigate prospectively the evolution of pain scores in the same individuals we have no data to support this assumption.</p><p id="par0035" class="elsevierStylePara elsevierViewall">Fear associated with allergy shots is even more multifactorial. It probably comprises, among other dimensions, fear of immediate pain due to injection, fear of local reactions (painful or troublesome) or even fear of severe reactions (needing treatment, hospitalisation or potentially life-threatening). Obviously fear scores are influenced by previous experiences and also by the information that people have (perceived risk). In our study, despite all patients having received oral and written information regarding the potential risks of allergen vaccines, it is worth mentioning that 89% of patients stated no fear regarding allergy shots, demonstrating once again, at least in experienced centres, that the perceived risk of severe adverse reactions to allergy shots is not a major issue for most of our patients in maintenance SCIT with polymerised allergen vaccines.</p><p id="par0040" class="elsevierStylePara elsevierViewall">In conclusion, in this study we found that most allergic patients receiving regular maintenance allergy shots with polymerised allergen vaccines in a specialised immunoallergology centre do not perceive this form of treatment as painful or dangerous. These results highlight the fact that most of these patients do not report any negative views towards the application of immunotherapy via subcutaneous injections.</p><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Ethical disclosure</span><p id="par0045" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">Protection of human and animal subjects.</span> The authors declare that no experiments were performed on humans or animals for this investigation.</p><p id="par0050" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">Right to privacy and informed consent.</span> The authors declare that no patient data appears in this article.</p><p id="par0055" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">Confidentiality of data.</span> The authors declare that no patient data appears in this article.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:2 [ 0 => array:2 [ "identificador" => "sec0005" "titulo" => "Ethical disclosure" ] 1 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "multimedia" => array:2 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1336 "Ancho" => 1523 "Tamanyo" => 60152 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Boxplots of visual analogue scales (VAS) scores for pain and fear.</p>" ] ] 1 => array:7 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:2 [ "leyenda" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">VAS – visual analogue scales, SCIT – subcutaneous immunotherapy; SD – standard deviation.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">SCIT duration \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">Number of patients \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">VAS pain (mean<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>SD) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">VAS fear (mean<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>SD) \t\t\t\t\t\t\n \t\t\t\t</td></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Less than 1 year \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">84 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">8.3<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>2.4<span class="elsevierStyleHsp" style=""></span>mm \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1.9<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.9<span class="elsevierStyleHsp" style=""></span>mm \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Between 1 and 2 years \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">66 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">9.1<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>3.1<span class="elsevierStyleHsp" style=""></span>mm \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1.8<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>1.1<span class="elsevierStyleHsp" style=""></span>mm \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Between 2 and 3 years \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">22 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">10.1<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>2.8<span class="elsevierStyleHsp" style=""></span>mm \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.8<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.7<span class="elsevierStyleHsp" style=""></span>mm \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Between 3 and 4 years \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">24 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">11.8<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>4.5<span class="elsevierStyleHsp" style=""></span>mm \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2.1<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>1.6<span class="elsevierStyleHsp" style=""></span>mm \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">More than 4 years \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">14 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">12.7<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>3.2<span class="elsevierStyleHsp" style=""></span>mm \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1.7<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>1.2<span class="elsevierStyleHsp" style=""></span>mm \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab337090.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Mean values of pain and fear VAS scores according to SCIT duration.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:10 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Immunotherapy for patients with persistent allergic rhinitis unsatisfied with free chronic pharmacotherapy" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "J.E. Gereda-Solari" 1 => "J. Loo" 2 => "A. Felices" 3 => "J. Casas" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Allergol Immunopathol" "fecha" => "2006" "volumen" => "34" "paginaInicial" => "102" "paginaFinal" => "106" ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Long-term clinical and immunological effects of allergen immunotherapy" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "A.Q. Eifan" 1 => "M.H. Shamji" 2 => "S.R. Durham" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/ACI.0b013e32834cb994" "Revista" => array:6 [ "tituloSerie" => "Curr Opin Allergy Clin Immunol" "fecha" => "2011" "volumen" => "11" "paginaInicial" => "586" "paginaFinal" => "593" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21986550" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cost-effectiveness of specific subcutaneous immunotherapy in patients with allergic rhinitis and allergic asthma" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "B. Bruggenjurgen" 1 => "T. Reinhold" 2 => "R. Brehler" 3 => "E. Laake" 4 => "G. Wiese" 5 => "U. Machate" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S1081-1206(10)60498-X" "Revista" => array:6 [ "tituloSerie" => "Ann Allergy Asthma Immunol" "fecha" => "2008" "volumen" => "101" "paginaInicial" => "316" "paginaFinal" => "324" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18814456" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A systematic review of measures used to assess chronic musculoskeletal pain in clinical and randomized controlled clinical trials" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "L. Litcher-Kelly" 1 => "S.A. Martino" 2 => "J.E. Broderick" 3 => "A.A. Stone" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jpain.2007.06.009" "Revista" => array:6 [ "tituloSerie" => "J Pain" "fecha" => "2007" "volumen" => "8" "paginaInicial" => "906" "paginaFinal" => "913" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17690014" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The concept of pain" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "W.R. Nielson" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ "tituloSerie" => "Clin J Pain" "fecha" => "2001" "volumen" => "17" "numero" => "Suppl. 4" "paginaInicial" => "S5" "paginaFinal" => "S7" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11783832" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0030" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Interpretation of visual analog scale ratings and change scores: a reanalysis of two clinical trials of postoperative pain" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "M.P. Jensen" 1 => "C. Chen" 2 => "A.M. Brugger" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Pain" "fecha" => "2003" "volumen" => "4" "paginaInicial" => "407" "paginaFinal" => "414" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14622683" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0035" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Determining mild, moderate and severe pain equivalency across pain-intensity tools in nursing home residents" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "K.R. Jones" 1 => "C.P. Vojir" 2 => "E. Hutt" 3 => "R. Fink" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Rehabil Res Dev" "fecha" => "2007" "volumen" => "44" "paginaInicial" => "305" "paginaFinal" => "314" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17551881" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0040" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pain measurement: visual analog scale (VAS) and verbal rating scale (VRS) in clinical trials with OTC analgesics in headache" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "B. Aicher" 1 => "H. Peil" 2 => "B. Peil" 3 => "H.C. Diener" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/0333102411430856" "Revista" => array:6 [ "tituloSerie" => "Cephalalgia" "fecha" => "2012" "volumen" => "32" "paginaInicial" => "185" "paginaFinal" => "197" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22332207" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0045" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Relationship between dental anxiety and pain perception during scaling" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "S. Sanikop" 1 => "P. Agrawal" 2 => "S. Patil" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Oral Sci" "fecha" => "2011" "volumen" => "53" "paginaInicial" => "341" "paginaFinal" => "348" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21959662" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0050" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Sex difference in injection site reactions with human vaccines" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "I.F. Cook" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Hum Vaccin" "fecha" => "2009" "volumen" => "5" "paginaInicial" => "441" "paginaFinal" => "449" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19377279" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/03010546/0000004100000004/v1_201307160011/S0301054612001115/v1_201307160011/en/main.assets" "Apartado" => array:4 [ "identificador" => "5561" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Research Letter" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/03010546/0000004100000004/v1_201307160011/S0301054612001115/v1_201307160011/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0301054612001115?idApp=UINPBA00004N" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 12 | 2 | 14 |
2024 October | 119 | 17 | 136 |
2024 September | 142 | 26 | 168 |
2024 August | 91 | 15 | 106 |
2024 July | 114 | 12 | 126 |
2024 June | 99 | 6 | 105 |
2024 May | 117 | 13 | 130 |
2024 April | 62 | 7 | 69 |
2024 March | 89 | 11 | 100 |
2024 February | 81 | 8 | 89 |
2024 January | 91 | 12 | 103 |
2023 December | 65 | 10 | 75 |
2023 November | 85 | 11 | 96 |
2023 October | 94 | 8 | 102 |
2023 September | 43 | 8 | 51 |
2023 August | 37 | 11 | 48 |
2023 July | 49 | 10 | 59 |
2023 June | 66 | 6 | 72 |
2023 May | 52 | 8 | 60 |
2023 April | 51 | 1 | 52 |
2023 March | 42 | 4 | 46 |
2023 February | 33 | 5 | 38 |
2023 January | 21 | 6 | 27 |
2022 December | 9 | 9 | 18 |
2022 November | 27 | 12 | 39 |
2022 October | 15 | 15 | 30 |
2022 September | 20 | 7 | 27 |
2022 August | 15 | 13 | 28 |
2022 July | 17 | 10 | 27 |
2022 June | 16 | 9 | 25 |
2022 May | 24 | 8 | 32 |
2022 April | 12 | 8 | 20 |
2022 March | 19 | 6 | 25 |
2022 February | 9 | 9 | 18 |
2022 January | 16 | 4 | 20 |
2021 December | 6 | 9 | 15 |
2021 November | 11 | 17 | 28 |
2021 October | 7 | 16 | 23 |
2021 September | 11 | 11 | 22 |
2021 August | 8 | 10 | 18 |
2021 July | 7 | 6 | 13 |
2021 June | 12 | 13 | 25 |
2021 May | 11 | 13 | 24 |
2021 April | 9 | 6 | 15 |
2021 March | 14 | 14 | 28 |
2021 February | 8 | 5 | 13 |
2021 January | 8 | 9 | 17 |
2020 November | 0 | 2 | 2 |
2020 September | 0 | 1 | 1 |
2020 August | 0 | 1 | 1 |
2020 July | 0 | 2 | 2 |
2020 May | 0 | 3 | 3 |
2020 April | 0 | 1 | 1 |
2020 March | 0 | 4 | 4 |
2020 February | 0 | 7 | 7 |
2020 January | 0 | 3 | 3 |
2019 December | 0 | 3 | 3 |
2019 November | 0 | 1 | 1 |
2019 August | 0 | 2 | 2 |
2019 July | 0 | 11 | 11 |
2019 June | 0 | 11 | 11 |
2019 May | 0 | 29 | 29 |
2019 April | 0 | 9 | 9 |
2019 March | 0 | 2 | 2 |
2019 February | 0 | 2 | 2 |
2019 January | 0 | 9 | 9 |
2018 April | 0 | 2 | 2 |
2018 March | 1 | 0 | 1 |
2018 February | 49 | 1 | 50 |
2018 January | 4 | 3 | 7 |
2017 December | 53 | 2 | 55 |
2017 November | 10 | 3 | 13 |
2017 October | 3 | 6 | 9 |
2017 September | 7 | 9 | 16 |
2017 August | 6 | 7 | 13 |
2017 July | 8 | 11 | 19 |
2017 June | 9 | 12 | 21 |
2017 May | 11 | 8 | 19 |
2017 April | 15 | 11 | 26 |
2017 March | 12 | 2 | 14 |
2017 February | 14 | 7 | 21 |
2017 January | 9 | 8 | 17 |
2016 December | 18 | 13 | 31 |
2016 November | 8 | 6 | 14 |
2016 October | 31 | 11 | 42 |
2016 September | 20 | 9 | 29 |
2016 August | 11 | 9 | 20 |
2016 July | 6 | 1 | 7 |
2016 June | 17 | 5 | 22 |
2016 May | 12 | 8 | 20 |
2016 April | 17 | 12 | 29 |
2016 March | 18 | 14 | 32 |
2016 February | 10 | 17 | 27 |
2016 January | 12 | 16 | 28 |
2015 December | 9 | 10 | 19 |
2015 November | 17 | 25 | 42 |
2015 October | 20 | 14 | 34 |
2015 September | 17 | 9 | 26 |
2015 August | 9 | 3 | 12 |
2015 July | 3 | 5 | 8 |
2015 June | 7 | 0 | 7 |
2015 May | 6 | 4 | 10 |
2015 April | 5 | 8 | 13 |
2015 March | 8 | 9 | 17 |
2015 February | 7 | 1 | 8 |
2015 January | 15 | 2 | 17 |
2014 December | 17 | 7 | 24 |
2014 November | 12 | 4 | 16 |
2014 October | 17 | 8 | 25 |
2014 September | 27 | 3 | 30 |
2014 August | 15 | 1 | 16 |
2014 July | 12 | 6 | 18 |
2014 May | 1 | 0 | 1 |
2014 April | 1 | 2 | 3 |
2014 March | 23 | 6 | 29 |
2014 February | 31 | 8 | 39 |
2014 January | 18 | 9 | 27 |
2013 December | 21 | 7 | 28 |
2013 November | 20 | 10 | 30 |
2013 October | 16 | 13 | 29 |
2013 September | 31 | 13 | 44 |
2013 August | 20 | 9 | 29 |
2013 July | 7 | 6 | 13 |